BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND EPS15, AF-1P, 2060, ENSG00000085832, P42566, MLLT5, AF1P AND Prognosis
4 results:

  • 1. Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options.
    Zhang CY; Liu S; Yang M
    World J Gastroenterol; 2022 Dec; 28(48):6827-6845. PubMed ID: 36632312
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic significance of lung metastasis-related finding in lenvatinib treatment for differentiated thyroid cancer.
    Yamazaki H; Iwasaki H; Masudo K; Toda S; Matsui A; Rino Y
    Endocrine; 2022 Dec; 78(3):543-551. PubMed ID: 36070050
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [The clinicopathological features and risk factors of recurrence in patients with mucinous borderline ovarian tumors].
    Sun L; Song Y; Li N; Yuan GW; Sun YC; Li N; Ma SK; Zhang X; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):589-594. PubMed ID: 28835081
    [No Abstract]    [Full Text] [Related]  

  • 4. Marital status is an independent prognostic factor for pancreatic neuroendocrine tumors patients: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
    Zhou H; Zhang Y; Song Y; Tan W; Qiu Z; Li S; Chen Q; Gao S
    Clin Res Hepatol Gastroenterol; 2017 Sep; 41(4):476-486. PubMed ID: 28416359
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.